INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

ALKSAlkermes plc.

CIK 0001520262

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells2 / 0
Max Insider Score32
Connections16with evidence

ALKS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
Gilbert Ray Cisneros, Jr.DSelf
ALKSAlkermes plc.
Purchase
BUY$1,001 – $15KSep 29, 2026Oct 12, 2026
traded Sep 29, 2026
+13dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    ALKERMES, INC. POLITICAL ACTION COMMITTEEFEC Form 1 connected organization: ALKERMES, INC. (exact legal-name match) · Nov 4, 2026
  • ← Insider ofevidence
    Reed JoshuaSVP, Chief Financial Officer · Oct 9, 2026
  • ← Insider ofevidence
    Whitaker Anne ClemDirector · Oct 9, 2026
21
RJ
Reed JoshuaSVP, Chief Financial Officer
ALKSAlkermes plc.
Option exercise
M
—
9,164 sh
Oct 8, 2026
Oct 9, 2026
traded Oct 8, 2026
+1d
SEC FORM 4

Evidence

9
RJ
Reed JoshuaSVP, Chief Financial Officer
ALKSAlkermes plc.
Option exercise
M—
9,164 sh
Oct 8, 2026Oct 9, 2026
traded Oct 8, 2026
+1dSEC FORM 4

Evidence

9
WC
Whitaker Anne ClemDirector
ALKSAlkermes plc.
Grant or award
A—
18.0K sh
Oct 7, 2026Oct 9, 2026
traded Oct 7, 2026
+2dSEC FORM 4

Evidence

24
RJ
Reed JoshuaSVP, Chief Financial Officer
ALKSAlkermes plc.
Tax withholding
F$163K
4,069 sh
Oct 8, 2026Oct 9, 2026
traded Oct 8, 2026
+1dSEC FORM 4

Evidence

9
WC
Whitaker Anne ClemDirector
ALKSAlkermes plc.
Grant or award
A—
7,239 sh
Oct 7, 2026Oct 9, 2026
traded Oct 7, 2026
+2dSEC FORM 4

Evidence

32
Gilbert Ray Cisneros, Jr.DSelf
ALKSAlkermes plc.
Purchase
BUY$15K – $50KJul 30, 2026Sep 4, 2026
traded Jul 30, 2026
+36dHOUSE PTR

Evidence

13
LN
Lurker NancyDirector
ALKSAlkermes plc.
Tax withholding
F$30K
901 sh
Apr 11, 2026Apr 13, 2026
traded Apr 11, 2026
+2dSEC FORM 4

Evidence

21
LN
Lurker NancyDirector
ALKSAlkermes plc.
Option exercise
M—
3,751 sh
Apr 11, 2026Apr 13, 2026
traded Apr 11, 2026
+2dSEC FORM 4

Evidence

17
LN
Lurker NancyDirector
ALKSAlkermes plc.
Option exercise
M—
3,751 sh
Apr 11, 2026Apr 13, 2026
traded Apr 11, 2026
+2dSEC FORM 4

Evidence

  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-09-04 · Sep 4, 2026
  • ← Lobbied forevidence
    CROSSROADS STRATEGIES, LLCLDA RA 2026 first quarter · Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    THORN RUN PARTNERSLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    LMH STRATEGIC SOLUTIONSLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    S-3 GROUPLDA Q2 2026 second quarter · ALC · Aug 26, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    SPLITOAK STRATEGIES LLCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    BALLARD PARTNERSLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    BGR GOVERNMENT AFFAIRSLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    PENN AVENUE PARTNERSLDA Q2 2026 second quarter · Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    MONUMENT ADVOCACYLDA RR 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Lurker NancyDirector · Apr 13, 2026
  • Lobbying

    $1.96M reported · de-duplicated
    2026 Q2 $930K in-house2026 Q1 $1.03M in-house
    • CROSSROADS STRATEGIES, LLC$60K2026 Q2 · posted Aug 26, 2026 · Pharmacy
    • THORN RUN PARTNERS$90K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • THORN RUN PARTNERS$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • LMH STRATEGIC SOLUTIONS$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • S-3 GROUP$80K2026 Q1 · posted Aug 26, 2026 · ALC
    • CROSSROADS STRATEGIES, LLC$50K2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • TODD STRATEGY GROUP$60K2026 Q1 · posted Aug 26, 2026 · Health issues
    • In-house report$930K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues, ALC, TAR
    • In-house report$1.03M2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues, ALC, TAR
    • S-3 GROUP$80K2026 Q2 · posted Aug 26, 2026 · ALC
    • SPLITOAK STRATEGIES LLC$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • MONUMENT ADVOCACY—2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • Brett GuthrieR$10KALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Michael A. RulliR$10KALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Aaron BeanR$10KALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Katherine M. ClarkD$5,000ALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Jon HustedR$5,000ALKERMES, INC. POLITICAL ACTION COMMITTEE
    Mike CareyR
    $5,000
    ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Neal P. DunnR$5,000ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Bill CassidyR$3,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Josh GottheimerD$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Donald G. DavisD$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Suzan K. DelBeneD$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Ashley MoodyR$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE